about
Airborne particulate matter exposure and urinary albumin excretion: the Multi-Ethnic Study of Atherosclerosis.State of the science on cardiometabolic risk after spinal cord injury: recap of the 2013 Asia pre-conference on cardiometabolic disease.Optimal reaction coordinate as a biomarker for the dynamics of recovery from kidney transplant.Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effectsArterial stiffness or endothelial dysfunction as a surrogate marker of vascular riskComparison between automated and manual measurements of carotid intima-media thickness in clinical practice.How long does craving predict use of methamphetamine? Assessment of use one to seven weeks after the assessment of craving: Craving and ongoing methamphetamine use.Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011.Serum chemokines herald disease activity and treatment response in vitiligo patients.
P2860
Q33946779-28B7E2AA-6D1D-494F-942A-BDB07FB443E4Q34612706-4818F261-D652-4B51-BC81-3E66B6613412Q35195419-6F34FE2B-9EB7-4BF1-B29A-8CDA0F77EF15Q35544692-D94765D9-6080-4A74-B2CD-220303ACC6DBQ36116666-C8D2CF64-3F32-4F2C-BABD-9ABE8602A85FQ36202850-D5C77725-F084-4FC6-92D1-854E277B0183Q36405147-FA6B8ECA-099B-4967-BD51-EE10AFABE3FAQ37367674-E1EC7AC2-CD4B-433E-BA38-DA4E0CEA9D86Q37412178-FC641FF3-369D-432C-AD5B-5B8D87B04125Q41104057-09001044-9F6D-487B-B36D-1E5B5D640369Q48194618-876E25C5-BD91-44D4-A7B0-A8B1211CF040
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Introduction to surrogate markers.
@ast
Introduction to surrogate markers.
@en
Introduction to surrogate markers.
@nl
type
label
Introduction to surrogate markers.
@ast
Introduction to surrogate markers.
@en
Introduction to surrogate markers.
@nl
prefLabel
Introduction to surrogate markers.
@ast
Introduction to surrogate markers.
@en
Introduction to surrogate markers.
@nl
P1433
P1476
Introduction to surrogate markers.
@en
P2093
Jay N Cohn
P304
P356
10.1161/01.CIR.0000133441.05780.1D
P407
P433
25 Suppl 1
P577
2004-06-01T00:00:00Z